WC
WST icon

Waterloo Capital’s West Pharmaceutical WST Stock Holding History

Waterloo Capital’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$696K Buy
1,938
+281
+17% +$85.9K 0.04% 292
2026
Q1 		$415K Sell
1,657
-236
-12% -$58.7K 0.03% 340
2025
Q4 		$521K Buy
1,893
+665
+54% +$182K 0.04% 292
2025
Q3 		$322K Buy
1,228
+166
+16% +$40.3K 0.02% 350
2025
Q2 		$232K Buy
+1,062
New +$227K 0.02% 413
2023
Q3 		– Sell
-572
Closed -$219K – 244
2023
Q2 		$219K Buy
+572
New +$204K 0.06% 176

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Waterloo Capital's WST Position: Q2 2026 in Review

Waterloo Capital increased its West Pharmaceutical (WST) stake by 17% in Q2 2026, buying an estimated $85.9K and bringing the position to 1,938 shares worth $696K. The position accounts for 0.04% of the portfolio, ranked #292.

Waterloo Capital first reported a position in WST in Q2 2023 and has held it in 6 quarters since. 834 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Waterloo Capital held 1,938 shares of West Pharmaceutical worth $696K as of Q2 2026.
  • Waterloo Capital bought 281 West Pharmaceutical shares in Q2 2026, an estimated $85.9K.
  • West Pharmaceutical made up 0.04% of Waterloo Capital's portfolio in Q2 2026, its #292 holding.
  • Waterloo Capital first reported a position in West Pharmaceutical in Q2 2023 and has held it in 6 quarters since.
  • 834 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Waterloo Capital's 13F filing for Q2 2026, filed 29 Jul 2026.